INESSS: Recherche

17381 à 17390 de 19830 résultats

Document | Usage optimal

Guide - Deep Vein Thrombosis and Pulmonary Embolism in Adults

Pertinence:

4%

1 / 6 RECURRENCE RISK FACTORS Currently, there is no consensus regarding the predictive value of any of the models that have been developed to assess the risk of venous thromboembolism (VTE) recurrenc

Type de fichier: application/pdf
Référencé à:

Guide - Deep Vein Thrombosis and Pulmonary Embolism in Adults

Document | Usage optimal

Guide - Deep Vein Thrombosis and Pulmonary Embolism in Adults

Pertinence:

4%

1 / 6 RECURRENCE RISK FACTORS Currently, there is no consensus regarding the predictive value of any of the models that have been developed to assess the risk of venous thromboembolism (VTE) recurrenc

Type de fichier: application/pdf
Référencé à:

Guide - Deep Vein Thrombosis and Pulmonary Embolism in Adults

Document | Usage optimal

Guide - Deep Vein Thrombosis and Pulmonary Embolism in Adults

Pertinence:

4%

1 / 6 RECURRENCE RISK FACTORS Currently, there is no consensus regarding the predictive value of any of the models that have been developed to assess the risk of venous thromboembolism (VTE) recurrenc

Type de fichier: application/pdf
Référencé à:

Guide - Deep Vein Thrombosis and Pulmonary Embolism in Adults

Document | Usage optimal

Guide - Deep Vein Thrombosis and Pulmonary Embolism in Adults

Pertinence:

4%

1 / 6 RECURRENCE RISK FACTORS Currently, there is no consensus regarding the predictive value of any of the models that have been developed to assess the risk of venous thromboembolism (VTE) recurrenc

Type de fichier: application/pdf
Référencé à:

Guide - Deep Vein Thrombosis and Pulmonary Embolism in Adults

Document | Usage optimal

Guide - Deep Vein Thrombosis and Pulmonary Embolism in Adults

Pertinence:

4%

1 / 6 RECURRENCE RISK FACTORS Currently, there is no consensus regarding the predictive value of any of the models that have been developed to assess the risk of venous thromboembolism (VTE) recurrenc

Type de fichier: application/pdf
Référencé à:

Guide - Deep Vein Thrombosis and Pulmonary Embolism in Adults

Document | Usage optimal

Guide - Deep Vein Thrombosis and Pulmonary Embolism in Adults

Pertinence:

4%

1 / 6 RECURRENCE RISK FACTORS Currently, there is no consensus regarding the predictive value of any of the models that have been developed to assess the risk of venous thromboembolism (VTE) recurrenc

Type de fichier: application/pdf
Référencé à:

Guide - Deep Vein Thrombosis and Pulmonary Embolism in Adults

Document | Usage optimal

Guide - Deep Vein Thrombosis and Pulmonary Embolism in Adults

Pertinence:

4%

1 / 6 RECURRENCE RISK FACTORS Currently, there is no consensus regarding the predictive value of any of the models that have been developed to assess the risk of venous thromboembolism (VTE) recurrenc

Type de fichier: application/pdf
Référencé à:

Guide - Deep Vein Thrombosis and Pulmonary Embolism in Adults

Document | Usage optimal

Guide - Deep Vein Thrombosis and Pulmonary Embolism in Adults

Pertinence:

4%

1 / 6 RECURRENCE RISK FACTORS Currently, there is no consensus regarding the predictive value of any of the models that have been developed to assess the risk of venous thromboembolism (VTE) recurrenc

Type de fichier: application/pdf
Référencé à:

Guide - Deep Vein Thrombosis and Pulmonary Embolism in Adults

Document | Usage optimal

Outil - Interactions médicamenteuses avec les anticoagulants oraux directs

Pertinence:

4%

1 / 9 INTERACTIONS MÉDICAMENTEUSES AVEC LES ANTICOAGULANTS ORAUX DIRECTS SOMMAIRE DES INTERACTIONS Apixaban Édoxaban Rivaroxaban Dabigatran AGENTS ANTI-INFECTIEUX SYSTÉMIQUES Antibactériens (macrolide

Type de fichier: application/pdf
Référencé à:

Outil - Interactions médicamenteuses avec les anticoagulants oraux directs

Document | Usage optimal

Outil - Interactions médicamenteuses avec les anticoagulants oraux directs

Pertinence:

4%

1 / 9 INTERACTIONS MÉDICAMENTEUSES AVEC LES ANTICOAGULANTS ORAUX DIRECTS SOMMAIRE DES INTERACTIONS Apixaban Édoxaban Rivaroxaban Dabigatran AGENTS ANTI-INFECTIEUX SYSTÉMIQUES Antibactériens (macrolide

Type de fichier: application/pdf
Référencé à:

Outil - Interactions médicamenteuses avec les anticoagulants oraux directs

Abonnez-vous à notre infolettre dès maintenant